Dr. Ju-Sheng Shieh has over a decade of experience serving as a general manager for multinational corporations. In recent years, he has focused primarily on the development of the biotechnology and medical sectors, accumulating decades of expertise in biotechnology innovation and healthcare business management. During this time, he has published several international papers as first author and secured more than ten international patents in the fields of biotechnology, pharmaceuticals, and medical engineering.
Dr. Shieh is the inventor of a patented technology for inducing (bio-pulsing) targeted exosomes, which led to the founding of Ascension Medical Biotechnology Co. This company is dedicated to research and development in the biotechnological and medical applications of mesenchymal stem cell-derived exosomes. Under his leadership, the company has successfully developed and manufactured targeted exosomes that meet a variety of therapeutic, cosmetic, and hair restoration needs.
Recognized as a pioneering figure in biotechnology and medical innovation, Dr. Ju-Sheng Shieh holds a Ph.D. from Nanjing University, as well as master’s degrees from The George Washington University in the United States and National Taiwan University. His cross-strait leadership and technical expertise have played a crucial role in advancing the biotech industry.
As Chairman of Ascension Medical Biotechnology Co. and President of the Health China Promotion Association, Dr. Shieh has led groundbreaking developments in the field of exosomes derived from mesenchymal stem cells. The company’s proprietary bio-pulsing exosome technology has been successfully commercialized for applications in healthcare and aesthetics.
Dr. Shieh’s work has earned him numerous prestigious accolades, including:
2019 Outstanding Taiwanese Businessman in Mainland China
2016 China Chronic Disease Management and Prevention Gold Award
2015 Gusu Leading Talent Award
Golden Summit Award for Outstanding Leadership
Golden Business Award from Taiwan’s Ministry of Economic Affairs
Executive Yuan Special Contribution Award
Between 1998 and 2003, he received over 20 major honors, including the Global Diamond Award and the Asia-Pacific Outstanding Performance Award.
A visionary leader in the biomedical industry, Dr. Shieh continues to drive innovation and deliver impactful solutions that enhance global healthcare.
Dr. Ju-Sheng Shieh has developed a patented technology for inducing (bio-pulsing) targeted exosomes, which led to the establishment of Ascension Medical Biotechnology Co. The company is dedicated to research and development in the biotechnological and medical applications of mesenchymal stem cell-derived exosomes. It successfully manufactures targeted exosomes that meet a range of needs in medicine, cosmetics, and hair restoration.
Dr. Shieh is the inventor of the world’s exclusive patented exosome biochemical pulse technology and the founder of Ascension Medical Biotechnology Co. The company focuses on the R&D of biomedical applications of exosomes, producing and commercializing targeted exosomes tailored for medical treatments, aesthetic enhancements, and hair growth solutions.
Targeted Bio-Pulsed Exosomes: A New Frontier in Women's Health and Regenerative Medicine
In addition to introducing naïve exosomes, Dr. Ju-Sheng Shieh will share the mechanism and characteristics of targeted biochemical pulse exosomes in his speech. He will use next-generation genome sequencing (NGS), polymerase chain reaction (QPCR), cell proliferation and animal experimental cases to analyze the mechanism of action (MOA) of exosomes, as well as the miraculous effects of targeted biochemical pulse exosomes in treating women's menopausal syndrome (GSM) and enhancing reproductive ability, as well as its mechanism of action (MOA).
In this talk, Dr. Ju-Sheng Shieh is going beyond just the basics of naïve exosomes. He’s going to introduce something far more exciting—targeted bio-pulsed exosomes. Now, what makes these so special? It’s not just their design—it’s how they work. Using tools like next-generation sequencing, qPCR, cell proliferation assays, and real animal models, he’ll break down the science behind them—their mechanism of action (MOA). But here’s where it gets really interesting: these exosomes aren’t just lab tools. They’ve shown real promise in treating Genitourinary Syndrome of Menopause (GSM) and even dramatically improve fertility. Dr. Shieh will take us inside the science, but also show us what this could mean for the future of women’s health.